Although it is known that hypercarbia in creases and benzodiazepines decrease cerebral blood flow (CBF), the effects of benzodiazepines on CBF re sponsiveness to CO2 are not well documented. The influ ence on CBF and CBF-C02 sensitivity of placebo or midazolam, which is a new water-soluble benzodiaz epine, was measured in eight healthy volunteers using the noninvasive 133Xe inhalation method for CBF de termination. Under normocarbia, midazolam decreased CBF from 40.6 ± 3.2 to 27.0 ± 5.0 ml 100 g-l min-1 (x ± SD). At a later session under hypercarbia, CBF was 58.8 ± 4.4 ml 100 g-l min-1 after administration of placebo, and 49.1 ± 10.2 ml 100 g-l min-1 after midazolam. The mean of the slopes correlating Paco2
Most agents used in anesthesia greatly alter cere bral blood flow (CBF). Inhalation anesthetics tend to increase CBF in a dose-related fashion, whereas most intravenous agents other than ketamine pro duce a decrease in CBF (Smith and Wollmann, 1972) . Although the linear relationship between arterial CO2 tension (P aC02) and CBF is well known (Reivich, 1964) , the influence of anesthetic agents on CBF sensitivity to CO2 is not well documented. It has been suggested that anesthetic agents in creasing CBF have an additive effect on CBF-C02 sensitivity, and that anesthetic agents reducing CBF decrease CBF-C02 sensitivity (Shapiro, 1981) . Benzodiazepines reduce CBF (Rockoff et al., 1980; Nugent et al., 1982) , but their effects on CBF-C02 sensitivity are not clear, because investigations of this phenomenon were performed in head trauma patients (Cotev and Shalit, 1976) , or benzodiaz epines were given in association with other drugs (Mendelow et al., 1981) .
To investigate the influence of benzodiazepines on CBF and CBF-C02 sensitivity without the con-and CBF was significantly steeper with midazolam (2.5 ± 1.2 ml 100 g-l min-1 mm Hg-l) than with placebo (1.5 ± 0. 4 ml 100 g-I min-1 mm Hg-l). Our re sults suggest that midazolam may be a safe agent to use in patients with intracranial hypertension, since it decreases CBF and thus cerebral blood volume; how ever, it should be administered with caution in non ventilated patients with increased intracranial pressure, since its beneficial effects on cerebrovascular tone can be readily counteracted by the increase in arterial CO2 ten sion induced by this drug. Key Words: Benzodiaz epines-Cerebral blood flow-C02 responsiveness Midazolam.
founding effects of pathological conditions or of other drugs, intravenous administration of midazo lam was investigated in healthy volunteers. This drug was chosen because, contrary to other benzo diazepines, it does not produce pain or phlebitis when injected into a peripheral vein.
MATERIALS AND METHODS
Eight healthy volunteers, four females and four males, were studied. Their mean age was 31 ± 4 years (x ± SD), and their mean weight was 62 ± 9 kg. The subjects had no previous medical problems and did not take regular medi cation or alcohol. Informed consent was obtained, and the Committee for Ethics in Human Research of our in stitution approved the study. The volunteers fasted for at least 12 h before the study, which always took place in the early afternoon.
An intravenous Teflon cannula was inserted into the dorsum of the hand, and a 5% glucose solution was ad ministered at the rate of 100 ml h-1. An arterial catheter was inserted into the left radial artery under local anes thesia, in order to measure continuously mean arterial blood pressure (MABP), and to withdraw arterial blood for measurement of blood gases.
CBF was measured with the 133Xe inhalation technique described by Obrist et al. (1976) . Sixteen 133Xe detection probes were fixed onto a plastic helmet and directed to ward both middle cerebral artery and posterior cerebral artery distribution bilaterally.
A mixture of oxygen and 4-5 mCi I33Xe was inhaled through a face mask with a closed breathing circuit during the I-min uptake period. An open circuit was utilized during the washout period, which lasted 10 min. End-tidal CO2 and I33Xe were monitored by continuous aspiration of gas samples through a small catheter within the mask at the rate of 1.5 ml min-I. CBF measurements were aver aged from the 16 desaturation head curves and calculated between the second and third minute of washout, using Risberg's Initial Slope Index adapted for inhalation, which represents mainly cortical flow (Risberg et aI., 1975) . To improve the understanding of our results, we considered the Initial Slope Index values as flows.
Four CBF measurements were made during two differ ent sessions. During the first session, CBF was measured twice under normocarbia: the first time 6 min after i. v.
injection of 2 ml of a normosaline solution, and the second time 6 min after an intravenous administration of midazolam (0.15 mg kg-I) over a 15-s period. At least 1 week later during the second session, the same procedure was repeated, and hypercarbia was produced by inhala tion of a mixture of 7% CO2 in O2, During the normocar bia session, 100% O2 was delivered in order to produce comparable arterial oxygen tension in all the groups.
Pac02 and MABP measured at the time of CBF determi nation were used to calculate cerebrovascular resistance (CVR) and CBF-C02 sensitivity. During the entire ex periment, the laboratory was kept in quiet darkness. An interval of 30 min was allowed between the two CBF measurements, so that background activity of I33Xe from the first measurement was found to be negligible « 10%). Five minutes before every investigation, the subjects were stimulated verbally in order to reproduce the same mental state during all the experiments. The slope cor relating CO2 and CBF was calculated for each subject.
A Student's t test was used for statistical comparison. Table 1 summarizes the results. Under nor mocarbic conditions, CBF decreased after the ad ministration of midazolam from 40.6 ± 3.2 to 27.0 ± 5.0 ml 100g-1 min-1 (34%; p < 0.001), and CVR increased from 2.8 ± 0.2 to 3.9 ± 0.6 mm Hg (m1100 g-l min-1)-1 (p < 0.001). Under hypercarbia, midazolam produced a decrease in CBF that was less significant (from 58.8 ± 4.4 to 49.1 ± 10.2 ml 100 g-l min-1 (p < 0.05); the change in CVR, from 2.8 ± 0.8 to 2.2 ± 0.4 mm Hg (ml 100 g-l min-1)-1 (p < 0.05), were also less significant. Midazolam de creased MABP only under normocarbia. Whereas the inhalation of 7% CO2 in O2 produced similar levels of hypercarbia, P aC02 was significantly higher (p < 0.05) in the normocarbic condition after the injection of midazolam. Figure 1 illustrates the changes in CBF and CVR that occurred after the injection of midazolam for a corrected P aC02 of 40 mmHg. Figure 2 shows the individual slopes and their mean, demonstrating the relationship between P aC02 and CBF, which can be described with the equations: CBF = 1.49 Paco2 -22.5, for placebo, and CBF = 2.50 Paco2 -65.5, for midazolam. The mean of the slopes after midazolam is not only shifted to the right but is also significantly steeper (p < 0.01).
RESULTS

DISCUSSION
The marked decreases in CBF after administra tion of midazolam under normocarbic conditions have been published elsewhere (Forster et aI., 1982) . The purpose of this study was to investigate any changes in CBF responsiveness to CO2 induced by this drug.
This responsiveness is impaired by many factors, such as atherosclerosis with aging (Yamaguchi et aI., 1979; Yamamoto et aI., 1980) , severe head trauma, and subarachnoid hemorrhage (Enevoldsen and Jensen, 1978; Mendelow et aI., 1981) Pharmacologi cal agents have also been demonstrated to influence cerebral vasomotor reactivity to CO2, Propranolol decreased the vasodilatory effect of hypercarbia without affecting cerebrovasoconstriction induced by hypocarbia (Aoyagi et al., 1976) . The influence of anesthetic agents seems to depend on the condi tions of the experiments. Halothane potentiates the vasodilatory effects of CO2 (Alexander et aI., 1964;  Christensen et aI., 1967), but when halothane is associated with arterial hypotension, CBF-C02 responsiveness may be lost (Okuda et aI., 1976) . Similar data have been published with respect to cy clopropane (Smith and Wollmann, 1972) . In the liter ature it appears generally that intravenous anesthet ic agents that increase CVR either decrease or do not influence the CBF vasomotor response to CO2 (Pierce et aI., 1962; Cotev and Shalit, 1976; Vern hiet et al., 1978; Shapiro, 1981) . Our results are not consistent with this or with the concept that agents that increase CBF also increase sensitivity to CO2, or that agents that decrease CBF decrease this sen sitivity (Shapiro, 1981) , as if the cerebrovasodila tory effect of CO2 would be potentiated by drugs that decrease CVR and would be counteracted by cere brovasoconstrictive agents. This difference in re sults can possibly be attributed to the fact that in the other studies on the effect of benzodiazepines on CBF-C02 sensitivity, nitrous oxide and fentanyl were combined with diazepam ( 1978), or the investigations were performed on head injury patients (Cotev and Shalit, 1976) . The increase in CBF-C02 sensitivity can only be attributed to the pharmacologic effect of midazo lam; it cannot be due to blood pressure changes, since throughout the experiments, blood pressure remained in the physiological range for CBF autoregulation, although the variations with mid azolam were greater than those with placebo. It cannot be attributed to individual reactivity, since the same volunteers were tested with placebo and benzodiazepine. The inhalation of 7% CO2 pro duced some distress only after administration of placebo, particularly during the last 5 min of the washout period, whereas after midazolam, no vol unteer recalled or expressed any discomfort during or after the experiment. On one hand, this influence on CBF should be minimal, since the flows were calculated from the washout curve at 2 and 3 min, when the discomfort from hypercarbia was mild; on the other hand, if it had occurred, this effect of stress would have produced a further increase in CBF than CO2 alone and steepened the slope of the placebo CO,JCBF relationship. Nevertheless, the difference in slope between placebo and mid azolam CO,JCBF relationships remains highly sig nificant (Fig. 2) .
This study demonstrates that CBF reactivity to CO2 is increased by intravenous injection of midazolam. CBF reactivity was tested only with hypercarbia and not with hypocarbia, because hyperventilation is not possible in spontaneously breathing volunteers heavily sedated by means that do not influence CBF.
The present results may have clinical implica tions. Midazolam is considered to be a safe drug for premedication, induction of anesthesia, or sedation, and can be an alternative to thiopental in neurosur gical patients because of its cerebrovascular prop erties (Forster et al., 1982) and its possible protect ing effect against cerebral hypoxia, which has been demonstrated in animals (Nugent et al., 1982) . Since midazolam increases CBF reactivity to CO2, it should be administered with caution in nonartifi cially ventilated patients prone to intracranial hypertension, because its cerebrovasoconstrictive effects tend to be counteracted by the increases of P aC02 due to the depressive respiratory effect of midazolam (Forster et al., 1982) , which might in duce or worsen intracranial hypertension.
